UNSPSC 51182054: Nandrolone benzoate

This classification denotes a therapeutic androgen and anabolic steroid with the molecular formula C25H30O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1665A8I95W, chemically known as estr-4-en-3-one, 17-(benzoyloxy)-, (17.beta.)-, but more generally known as nandrolone benzoate, which bears US NIH Compound Identifier 227796. European Medicines Agency schedules nandrolone benzoate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09148MIG.

Most nations, for tariff purposes, schedule nandrolone benzoate under HS 29372900. SMILES: C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2OC(=O)C4CCCCC4)CCC5=CC(=O)CC[C@H]35.

UNSPSC 51182054 Nandrolone benzoate is a Commodity code that covers procurement of this anabolic steroid pharmaceutical product by state and local health agencies, correctional facilities, and veterinary services. The code reflects purchases of nandrolone benzoate for legitimate medical use — primarily intramuscular injection formulations prescribed in clinical settings for conditions including muscle-wasting disorders, severe anemia, and certain bone-density deficiencies. State and local governments acquire this product through standard pharmaceutical supply channels, typically via established vendor contracts or standing purchase orders with licensed pharmaceutical distributors, subject to DEA scheduling and state pharmacy licensing requirements.

The most recent state and local contract opportunities block contains no records for this code, indicating minimal or no recent procurement activity under UNSPSC 51182054 at the state and local level. Without current solicitations, geographical concentration and representative recent opportunities cannot be characterized from the source.